Healey & AMG Center for ALS – new drug regimen test DNL343
Healey & AMG Center for ALS announces new drug regimen for testing DNL343 in HEALEY ALS Platform Trial The HEALEY ALS Platform Trial is adding a new investigational drug, DNL343, to continue to research new treatments for ALS (Amyotrophic Lateral Sclerosis or Lou Gehrig’s disease). The trial, led by the Sean M. Healey & AMG Center […]
Healey & AMG Center for ALS – new drug regimen test DNL343 Read More »